Skip to content

Risk identification and personalized prevention strategy for elderly sarcopenia based on AI and wearable technology

Risk identification and personalized prevention strategy for elderly sarcopenia based on AI and wearable technology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092553
Enrollment
Unknown
Registered
2024-11-19
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Individualized intervention group:AI assisted decision intervention
Routine intervention group:Traditional health education

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1.Live there for at least 36 months and will not leave for the next 3 years; 2.Age 60 or above; 3.Primary school or above; 4.A family doctor team service contract has been signed with the local community health service center; 5.Own and be able to use a smartphone; 6.Volunteer to participate in the study and sign the informed consent; 7.The PRE-SARC assessment identified a high risk of sarcopenia;

Exclusion criteria

Exclusion criteria: 1.Diagnosis of stroke coronary heart disease or myocardial infarction and severe cardiac insufficiency (NYHA III or IV); 2.Diseases requiring urgent treatment, such as acute infection, hypertensive crisis, diabetic ketoacidosis, etc; 3.Severe abnormal liver and kidney function, the presence of autoimmune disease or other serious fatal diseases; 4.Has been diagnosed with various malignancies; 5.Have a psychiatric disorder or alcohol problem and are unable to exercise self-control or express their will; 6.Severely limited physical activity, bedridden and unable to stand; 7.Unable to cooperate with or explicitly refused to participate in the study;

Design outcomes

Primary

MeasureTime frame
The improvement of sarcopenia-related indicators such as changes in risk value of PRE-SARC, incidence of sarcopenia, muscle mass, muscle strength and physical function, as well as the incidence of sarcopenia-related adverse outcomes (falls, fractures, readmission, disability, and death);

Secondary

MeasureTime frame
Changes in risk factors for sarcopenia (such as smoking cessation rate, physical activity, alcohol consumption rate, dietary habits);Changes in health-related indicators such as heart rate, blood pressure, blood oxygen, calf circumference, upper arm circumference, waist circumference, hip circumference, body mass index (BMI), and body fat distribution;Changes in nutritional status (malnutrition score, creatinine, eGFR, blood glucose, albumin, glycated hemoglobin, etc.);Changes in quality of life;

Countries

China

Contacts

Public ContactJirong Yue

West China Hospital of Sichuan University

yuejirong11@hotmail.com+86 28 85421550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026